Article Information
History
- January 26, 2022.
Article Versions
- Version 1 (January 3, 2022 - 21:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brian J. Willett1,*,
- Joe Grove1,
- Oscar A. MacLean1,
- Craig Wilkie2,
- Nicola Logan1,
- Giuditta De Lorenzo1,
- Wilhelm Furnon1,
- Sam Scott1,
- Maria Manali1,
- Agnieszka Szemiel1,
- Shirin Ashraf1,
- Elen Vink1,
- William T. Harvey1,
- Chris Davis1,
- Richard Orton1,
- Joseph Hughes1,
- Poppy Holland3,
- Vanessa Silva3,
- David Pascall4,
- Kathryn Puxty3,
- Ana da Silva Filipe1,
- Gonzalo Yebra5,
- Sharif Shaaban5,
- Matthew T. G. Holden5,6,
- Rute Maria Pinto1,
- Rory Gunson3,
- Kate Templeton7,
- Pablo R. Murcia1,
- Arvind H. Patel1,
- The COVID-19 Genomics UK (COG-UK) Consortium§,
- John Haughney3,
- David L. Robertson1,
- Massimo Palmarini1,
- Surajit Ray2 and
- Emma C. Thomson1,3,8,*
- 1MRC-University of Glasgow Centre for Virus Research, University of Glasgow, UK
- 2School of Mathematics & Statistics, University of Glasgow, UK
- 3NHS Greater Glasgow & Clyde, Glasgow, UK
- 4MRC Biostatistics Unit, University of Cambridge, U.
- 5Public Health Scotland
- 6School of Medicine, University of St Andrews, UK
- 7NHS Lothian, Edinburgh, UK
- 8London School of Hygiene and Tropical Medicine, London, UK
- ↵*Corresponding authors: Professor Emma Thomson and Professor Brian Willett, MRC-University of Glasgow Centre for Virus Research, UK, G61 1QH., emma.thomson{at}glasgow.ac.uk and brian.willett{at}glasgow.ac.uk
Posted January 26, 2022.
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
